TUCSON, Ariz. — John Ramsey urged Savannah Guthrie’s family to closely monitor the investigation into the disappearance of Nancy Guthrie as the case reached 109 days without a confirmed suspect, public records and media interviews show.

The 84-year-old was last seen Jan. 31 and reported missing Feb. 1, and local, state and federal authorities have since collected thousands of hours of surveillance footage, submitted unidentified DNA for analysis and continued to process tips, according to statements from investigators and reporting from news organizations.

Ramsey, whose daughter JonBenét Ramsey was murdered in 1996 in a case that remains unsolved, spoke publicly about the Guthrie investigation during an interview with journalist Brian Entin and urged relatives to ask detailed questions about forensic testing and investigative progress. In the interview, Ramsey said families should not assume investigators have exhausted every lead and encouraged them to press for information about DNA testing and genetic genealogy, according to published excerpts of the interview.

Officials with the Pima County Sheriff’s Department and law enforcement partners have confirmed that the investigation remains active and ongoing, with no suspects named and no arrests announced. Investigators briefed the public at intervals after Nancy Guthrie’s disappearance and said they have received assistance from federal agencies, collected thousands of videos from traffic and residential cameras, and submitted DNA samples to state and federal laboratories for comparison and advanced analysis.

Public interest in the case has been intense since the disappearance was reported, and online speculation has at times targeted the Guthrie family despite law enforcement statements that immediate family members were cleared early in the inquiry. Authorities have not publicly identified a suspect or charged anyone in the case, and Pima County officials have repeatedly urged the public to submit tips and to avoid spreading unverified claims.

Investigators have described a wide-ranging evidence collection effort. Authorities said they have analyzed video from intersections and doorbell cameras near the Catalina Foothills-area home where Nancy Guthrie lived, reviewed cellphone and digital records, and followed up on leads generated by public tips. Law enforcement also said in public briefings that a masked individual initially flagged by investigators was later determined to be unrelated to the case.

Genetic genealogy has been used in the investigation, law enforcement sources and media reports indicate. Officials acknowledged that unidentified DNA is under analysis and that results from advanced testing and genealogical comparisons can take time as samples are reviewed and matched through investigative techniques that often involve multiple laboratories and databases. Federal guidance and public reports note that genetic genealogy has helped solve hundreds of cold cases in recent years, but officials have cautioned that not every sample yields usable genealogical leads.

The timeline released by authorities shows that the investigation accelerated in the days after Nancy Guthrie was reported missing and has continued through subsequent months. In early February, search teams and police canvassed the neighborhood, gathered surveillance footage and interviewed witnesses. By mid-February, authorities reported signs that suggested possible abduction and enlisted federal support, according to law enforcement statements. In March, investigators broadened forensic testing, including genetic genealogy work, and in April and May the probe expanded to analyze thousands of hours of video and additional digital records.

Family members and supporters have publicly appealed for information while also asking for privacy as investigators work through leads. Savannah Guthrie and her family have not provided frequent public updates beyond occasional social media posts and statements asking for assistance in locating Nancy Guthrie. Savannah Guthrie’s husband posted a tribute on Mother’s Day and thanked those who have shared tips and shown support.

Public pressure on the Pima County Sheriff’s Department increased as the 109-day mark approached. Social media users and some local commentators questioned the pace of public updates, noting that routine department posts sometimes focused on traffic incidents and unrelated arrests rather than investigative developments in the Guthrie case. Pima County officials have said they will release information as it becomes verified and have urged the public to rely on official channels for accurate updates.

Investigators have described the case as complex. Law enforcement sources said the area’s dense web of traffic cameras and residential doorbell systems has produced a large volume of footage that requires time-consuming review. Officials said they are cross-referencing timestamps and synchronizing multiple camera angles to reconstruct movements near the Guthrie residence and surrounding streets. Those efforts, law enforcement officials told reporters, are part of a methodical investigative process intended to ensure that leads are followed and evidence is properly documented.

Criminal justice experts who have commented in media coverage note that high-profile cases often attract intense public scrutiny and that families affected by such cases may seek outside advice or advocacy. John Ramsey’s comments — drawing on his experience with an unsolved, high-profile case — were framed by him as guidance for families navigating long, uncertain investigations. Ramsey said that questioning investigators and seeking clarity about testing and evidence is a way for families to remain informed, according to published interview excerpts.

Law enforcement officials continue to appeal for the public’s help. Authorities have asked anyone with information, no matter how small it may appear, to contact investigators through established tip lines. Investigators said leads continue to be evaluated and that the priority remains locating Nancy Guthrie and determining the circumstances surrounding her disappearance.

As the investigation marks more than three months, forensic work continues. Officials confirmed to reporters that unidentified DNA from the scene and other samples remain under analysis in state and federal labs, a process that can include multiple rounds of testing, comparison against national databases and the application of investigative genetic genealogy where appropriate. Agencies involved in the probe emphasized that forensic timelines can vary widely depending on sample quality and the complexity of the comparisons.

Authorities also emphasized that open, accurate public communication is essential and that investigators will release information when it is verified and legally appropriate. Law enforcement officials reiterated that speculation and the spread of unconfirmed theories can hinder investigative efforts and complicate the work of locating missing persons.

The Guthrie disappearance has prompted renewed discussion in media and among advocacy groups about how missing-person investigations are conducted and how families are briefed. Some commentators highlighted the role of advanced forensic methods, including genetic genealogy, in providing new investigative avenues, while others stressed the need for careful handling of sensitive evidence and respect for privacy as inquiries progress.

For now, the investigation continues without a named suspect, and law enforcement agencies say they are pursuing all credible leads. John Ramsey’s public remarks have amplified calls for transparency and for families to take an active role in seeking updates, but authorities cautioned that the investigative process requires time to ensure accuracy. The Pima County Sheriff’s Department and partner agencies maintain that their work is ongoing and that tips from the public remain a critical component of the probe.

Anyone with information related to Nancy Guthrie’s disappearance is urged to contact the Pima County Sheriff’s Department tip line or the FBI’s Phoenix Division. Authorities say even seemingly minor details can assist investigators as they continue to review forensic results and thousands of hours of video evidence.

Laura Paxton

Good evening, everyone, and welcome to Quadient’s First Quarter 2026 Revenue Call. I’m Laura Paxton, Head of Investor Relations at Quadient, and I’m here today with Geoffrey Godet, CEO; and Laurent Du Passage, CFO.

We will have a short presentation followed by Q&A, and then you can submit your questions in writing through the web or ask questions live by dialing into the conference call. The presentation and press release are now available on our website at invest.quadient.com, and a replay of the call will also be available on our website.

Thank you very much for joining us this evening. I will now hand over to you, Geoffrey.

Geoffrey Godet
CEO & Director

Thank you, Laura, and welcome, Laurent. Good evening, everyone. Starting on Slide 5. So let me start with a brief reminder of some of the key dynamics shaping our performance as we entered 2026.

As you remember, as I have outlined during our full year results, we continue to operate in an environment that has been driven by key structural trends, right? So first one is the acceleration of digitalization, supported in particular by AI and invoicing mandates.

And the second one is the ongoing structural evolution of the Mail market. Alongside our full year result in 2025, we also announced a major organization of the Executive Committee with a very clear intention, align the leadership with our operational priorities and most importantly, put our digital automation platform at the center of the company with the clear goals to accelerate both growth and innovation.

Now this has already enabled a sharper and more coordinated go-to-market

Three major hospital systems on Monday filed lawsuits accusing CVS Health and its subsidiaries of running a secret scheme that allegedly siphoned hundreds of millions of dollars away from hospitals serving vulnerable and uninsured patients.

The lawsuits – filed by Mount Sinai in New York, University of Michigan Health and Sparrow Hospital, and the University of Kansas Hospital Authority – claim CVS manipulated reimbursements tied to the federal 340B Drug Pricing Program and kept the difference as profit, according to complaints obtained by FOX Business.

The hospitals allege insurers and patients paid full price for specialty drugs, but CVS later reduced payments to hospitals through affiliated companies, including CaremarkPCS, CVS Specialty, Caremark LLC and WellPartner.

The lawsuits estimate massive financial losses. Mount Sinai claims more than $121 million in losses since 2020. University of Michigan and Sparrow allege more than $66 million in losses. University of Kansas Hospital Authority alleges nearly $62 million in losses.

CVS, WALGREENS PULL BACK COVID VACCINES IN MORE THAN A DOZEN STATES FOLLOWING NEW GUIDELINES

The lawsuits claim CVS manipulated reimbursements tied to the federal 340B Drug Pricing Program and kept the difference as profit. (Zak Bennett/Bloomberg via Getty Images)

At the center of the cases is the federal 340B Drug Pricing Program, which allows qualifying hospitals to buy expensive medications at discounted prices and use the savings to help fund community health services.

“Hospitals use 340B savings to provide, for example, free care for uninsured patients, offer free vaccines, provide services in mental health clinics, and implement medication management and community health programs,” the American Hospital Association states on its website.

A spokesperson for CVS told FOX Business in an email: “We do not comment on matters that are subject to ongoing litigation and remain focused on serving our customers and executing our business priorities.”

The University of Michigan complaint claims CVS and its subsidiaries “diverted (and continue to divert) 340B revenue for themselves by implementing a secret pricing scheme for 340B drugs, which required cooperation among its affiliated entities within the 340B drug supply chain.”

“CaremarkPCS charged the plan/payor the original higher amount, and the 340B eligible patient the original higher copay just so that defendants retain 340B profits,” the Mount Sinai complaint alleges.

CVS CAREMARK ORDERED TO PAY $290M AFTER MEDICARE FRAUD SCHEME EXPOSED BY FORMER AETNA WHISTLEBLOWER

The complaints point to examples involving high-cost specialty drugs, including Stelara, which is used to treat chronic inflammatory conditions like plaque psoriasis, according to Stelara’s website.

The Michigan lawsuit cites one example in which a Stelara prescription allegedly generated more than $24,000 for the University of Michigan’s specialty pharmacy, but only about $18,000 when processed through CVS Specialty — a difference of more than $6,500.

“The $6,523.18 reflects the ‘spread’ artificially created and pocketed by the defendants as pure profit,” the complaint alleges.

The lawsuits also accuse CVS of refusing audit requests and terminating some pharmacy agreements after hospitals raised concerns.

“Defendants refused to permit an audit and terminated plaintiff from the 340B Contract Pharmacy Arrangement, in retaliation for uncovering the fraudulent scheme described herein and seeking to fulfill their obligations under the 340B Program and HRSA regulations,” the Kansas complaint alleges.

ANTI-THEFT MEASURES AT CVS ARE ‘WORSE FOR BUSINESS THAN ORGANIZED SHOPLIFTING,’ COLUMNIST ARGUES

Sparrow Hospital in Lansing, Michigan, is part of the University of Michigan Health system. (Google Maps)

GET FOX BUSINESS ON THE GO BY CLICKING HERE

The hospitals are seeking damages, repayment of alleged profits, court orders requiring CVS to turn over records and for the business to stop the alleged practices.

Last year, a federal judge ordered CVS Health’s Caremark to pay nearly $290 million after a whistleblower accused the company of overcharging Medicare on prescription drugs.

A spokesperson for University of Michigan Medicine told FOX Business: “Because this involves pending litigation, I have no information to share.”

FOX Business reached out to Mount Sinai and the University of Kansas Hospital Authority for comment.

FOX Business’ Alexandra Koch contributed to this report.